A Study of Cognitive Health in Survivors of Prostate Cancer

Recruiting in Palo Alto (17 mi)

+6 other locations

Overseen byKevin Liou

Age: 18+

Sex: Male

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Memorial Sloan Kettering Cancer Center

No Placebo Group

Trial Summary

What is the purpose of this trial?The purpose of this study is to collect information that may help the researchers understand the relationship between prostate cancer survivors' experiences of cancer-related cognitive dysfunction (CRCD) and their other conditions (co-morbid factors), including anxiety, depression, and insomnia. The researchers will also find out how additional things may contribute to CRCD, including social factors, the characteristics of participants' prostate cancer, and the type of cancer treatment or other medications they received.

Eligibility Criteria

Inclusion Criteria

English-speaking

History of histologically documented PC of any stage

No evidence of PC Disease

+1 more

Participant Groups

1Treatment groups

Experimental Treatment

Group I: Survivors of Prostate CancerExperimental Treatment1 Intervention

This is a cross-sectional study with a one-time data collection process and no subsequent follow-ups. If patients did not opt out of receiving study-specific text communications, they may also receive text messages with reminders about surveys and/or direct links to REDCap to complete the surveys. Text-based communications will be delivered using the secure, HIPAA-compliant Mosio texting platform developed for clinical research.